Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Year-over-year earnings per share growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P54
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
17.73%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 17.54% |
| Q2 2025 | -7.55% |
| Q1 2025 | 10.17% |
| Q4 2024 | -268.75% |
| Q3 2024 | 11.11% |
| Q2 2024 | 10.00% |
| Q1 2024 | -115.63% |
| Q4 2023 | 316.95% |
| Q3 2023 | -15.69% |
| Q2 2023 | -116.72% |
| Q1 2023 | 600.00% |
| Q4 2022 | -232.61% |
| Q3 2022 | 193.88% |
| Q2 2022 | 12.50% |
| Q1 2022 | -473.33% |
| Q4 2021 | 122.39% |
| Q3 2021 | 16.25% |
| Q2 2021 | -37.93% |
| Q1 2021 | -34.88% |
| Q4 2020 | -118.70% |
| Q3 2020 | 1100.00% |
| Q2 2020 | 65.15% |
| Q1 2020 | -94.12% |
| Q4 2019 | 17.07% |
| Q3 2019 | -236.67% |
| Q2 2019 | 137.04% |
| Q1 2019 | -15.71% |
| Q4 2018 | -11.11% |
| Q3 2018 | 21.25% |
| Q2 2018 | -26.98% |
| Q1 2018 | -57.50% |
| Q4 2017 | 55.06% |
| Q3 2017 | -21.92% |
| Q2 2017 | -12.31% |
| Q1 2017 | -14.04% |
| Q4 2016 | -62.86% |
| Q3 2016 | 5.41% |
| Q2 2016 | -27.59% |
| Q1 2016 | 0.00% |